Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that plays a central role in the cellular response to DNA damage and redox regulation against oxidative stress. APE1/Ref-1 functions in the DNA base excision repair pathway, the redox regulation of several transcription factors, and the control of intracellular redox status through the inhibition of reactive oxygen species (ROS) production. APE1/Ref-1 is predominantly localized in the nucleus; however, its subcellular localization is dynamically regulated and it may be found in the mitochondria or elsewhere in the cytoplasm. Studies have identified a nuclear localization signal and a mitochondrial target sequence in APE1/Ref-1, as well as the involvement of the nuclear export system, as determinants of APE1/Ref-1 subcellular distribution. Recently, it was shown that APE1/Ref-1 is secreted in response to hyperacetylation at specific lysine residues. Additionally, post-translational modifications such as phosphorylation, S-nitrosation, and ubiquitination appear to play a role in fine-tuning the activities and subcellular localization of APE1/Ref-1. In this review, we will introduce the multifunctional role of APE1/Ref-1 and its potential usefulness as a therapeutic target in cancer and cardiovascular disease.
INTRODUCTION
Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1), also known as APEX1, is the mammalian ortholog of Escherichia coli Xth (exonuclease III). APE1/Ref-1 functions as an apurinic/apyrimidinic endonuclease in the DNA base repair pathway. Oxidative DNA lesions, including apurinic/apyrimidinic (AP) sites, have been reported as occuring at an estimated rate of 1.5×10 5 residues/cell/day. 1 APE1/Ref-1 also modulates the redox status, and thereby the activity of several transcription factors such as activator protein-1 (AP-1), nuclear factor kappa B (NF-B), p53, the cAMP response element binding protein (CREB), and hypoxia-inducible factor-1- (HIF-1). The formation of disulfide bonds is thought to be a necessary step for the redox activities of APE1/Ref-1, with cysteine residues C65, C93, and C99 playing important roles in the thiol-mediated redox reactions. copies/cell) with a long half-life. 5 The human APE1/Ref-1 gene is approximately 3 kb in length; it consists of four introns and five exons and is located on chromosome 14q11.2-12. 6 The human APE1/Ref-1 cDNA is approximately 1.4 kb in length and the mature 954-nucleotide sequence encodes a protein of 318 amino acids, with a molecular weight of 36.5 kDa. 7 BLAST multiple alignment of the human APE1/Ref-1 amino acid sequence with sequences from different mammalian species demonstrated that the C-terminus is conserved more than the N-terminus. This comparison also revealed a high degree of identity (93-99%) between the protein sequence from human APE1/Ref-1 and the protein sequences from other mammals: rat (Rattus norvegicus, 93%), mouse (Mus musculus, 94%), cow (Bos taurus, 94%), dog (Canis lupus familiaris, 95%), and chimpanzee (Pan troglodytes, 99%). Interestingly, there is only a single difference between the human and chimpanzee sequences, with the aspartic acid (D) at position 148 changed to glutamic acid (E).
SUBCELLULAR LOCALIZATION OF APE1/Ref-1
APE1/Ref-1 is predominantly localized in the nucleus where it performs DNA repair and transcriptional regulatory activities. These nuclear functions of APE1/Ref-1 are presumed to be essential for cell viability and genomic stability. Despite the presence of strong nuclear targeting elements within the APE1/Ref-1 sequence, cytoplasmic and mitochondrial localizations of the protein have also been reported in some cell types, such as those with high metabolic or proliferative rates. 4, 8, 9 Mainly, the cytoplasmic or mixed cytoplasmic and nuclear staining pattern of APE1/Ref-1 in some cell populations is unexpected for a presumably nuclear protein 10 and suggests multiple potential functions for APE1/Ref-1. 9 Nuclear localization of APE1/Ref-1 was significantly decreased by the deletion of 20 N-terminal amino acids, suggesting that this sequence contains a nuclear localization signal (NLS). Furthermore, fusion of these 20 N-terminal residues to EGFP resulted in it being localized to the nucleus. 11 The nuclear translocation of APE1/Ref-1 is also supported by the interaction of APE1/Ref-1 with karyopherin , an adaptor protein that recognizes the proteins containing the NLS and plays an important role in the import of nuclear proteins. 11, 12 The role of the nuclear export system (NES) in the subcellular localization of APE1/Ref-1 has been previously investigated. S-nitrosoglutathione (GSNO), an S-nitrosating agent, induces cytoplasmic translocation of APE1/Ref-1 in an exportin-1-independent manner. Exportin-1, also known as chromosome region maintenance 1 (CRM1), is a eukaryotic protein that mediates the nuclear export of proteins. Mutation analyses demonstrate that the point mutation of S-nitrosation sites, such as Cys93 and Cys310, inhibits the cytoplasmic redistribution of APE1/Ref-1, indicating that the cytoplasmic translocation is dependent on S-nitrosation. 13 The 15 The translocation of APE1/Ref-1 to the mitochondria in HeLa cells has also been observed following oxidative stress induced by hydrogen peroxide, menadione, or hypoxia. 16 Mutation analyses have confirmed that the MTS of APE1/Ref-1 is located in the region containing the 289 to 318 residues of the C-terminus. The MTS sequence is normally masked by the N-terminal structure and this masking prevents interaction between MTS and the mitochondrial transporter, TOM protein. 16 21,22 Serum APE1/Ref-1 autoantibodies have been detected in lung cancer patients at significantly higher levels than in healthy controls, suggesting that these may be used as a potential marker for lung cancer. 23 Recently, APE1/Ref-1 levels in biological samples such as serum and urine have been reported using a newly developed, sandwich enzyme-linked immunosorbent assay. Jin et al found that the levels of APE1/Ref-1 were higher in serum from patients with coronary artery disease than in the serum from control patients. 24 Recently, it has been reported that plasma or urine APE1/Ref-1 levels significantly increase in bladder cancer patients; the area under the curve analysis showed diagnostic values with high specificity and sensitivity. 25, 26 Although the underlying mechanisms for secreted APE1/Ref-1 are yet to be fully delineated, a few reports have been able to provide some insight into its biological functions. Recombinant wild-type APE1/Ref-1 displayed anti-inflammatory activity in endothelial cells 20 and acetylated APE1/Ref-1 was found to be able to bind to the receptor for advanced glycation end products, which resulted in apoptosis in cells. 22 
POST-TRANSLATIONAL MODIFICATIONS OF APE1/Ref-1
Post-translational modifications (PTM) are covalent and enzymatic modifications of proteins that occur after translation, and are important for forming the mature protein products and for cellular signaling pathways. Phosphorylation, a type of PTM, is a common mechanism for the regulation of enzyme activity in target proteins. APE1/Ref-1 is a target substrate for phosphorylation by serine/threonine casein kinases and protein kinase C. 28, 29 The phosphorylation of APE1/Ref-1 has been shown to abolish its DNA repair activity 30 and to increase the redox activity of transcription factor AP-1 in response to ROS.
28,31
The S-nitrosation of cysteine residues is another important PTM. The S-nitrosation of APE1/Ref-1 induced by exposure to GSNO results in the cytoplasmic localization of the protein, either by stimulating nuclear export or by inhibiting nuclear import. 13 Acetylation of target proteins is yet another important PTM. APE1/Ref-1 can be acetylated by histone acetyltransferase p300. 32 Histone acetyltransferase p300 is activated by intracellular calcium and the acetylation of APE1/Ref-1 at K6 or K7 enhances its binding to negative calcium response elements. APE1/Ref-1 is also known to bind with silent mating type information regulation 2 homolog 1 (Sirtuin 1, SIRT1), which deacetylates the K6 and K7 lysine residues. 33 The acetylation of residues K6 and K7 of APE1/Ref-1 is known to be a key step for its secretion in cultured cells. 21 Finally, APE1/Ref-1 is also subjected to PTM through ubiquitination by E3 ubiquitin ligase at multiple lysine residues near its N-terminus. 34 The degradation of APE1/Ref-1 is mediated by mouse double minute 2 (MDM2), which is involved in ubiquitination. 35 In contrast to the predominantly nuclear localization of APE1/Ref-1, the ubiquitinated APE1/Ref-1 protein is clearly localized in the cytoplasm, 35 suggesting underlying mechanisms for the cytoplasmic localization of APE1/Ref-1. 36 In lung cancer patients, nuclear and cytoplasmic APE1/Ref-1 expression markedly increases in the tissues from tumor regions. An alteration to cellular antioxidant systems, which leads to enhanced superoxide production and lipid peroxidation, is observed in the tumor regions of lung cancers. 37 The 45 APE1/Ref-1 controls intracellular ROS via the inhibition of rac1, a subunit of the NADPH oxidase system, and increases the bioavailability of nitric oxide by enhancing the activity of endothelial nitric oxide synthase. 43, 46 APE1/Ref-1 has been found to suppress cytokine-induced monocyte adhesion as well as the expression of vascular cell adhesion molecules in endothelial cells. 47, 48 In endothelial cells, oxidized low-density lipoprotein or PKCII induces serine 36 phosphorylation of p66shc, which is inhibited by APE1/Ref-1 overexpression. 49 Recently, an NLS-deletion mutant of APE1/Ref-1, which is exclusively localized in the cytoplasm, has been found to inhibit TNF--induced VCAM-1 expression in the cultured endothelial cells, suggesting an anti-inflammatory function for cytoplasmic APE1/Ref- 1. 4 APE1/Ref-1 may also be involved in the regulation of blood pressure. Heterozygous APE1/Ref-1(+/-) mice are hypertensive and display impaired endothelium-dependent vasorelaxation and reduced vascular NO levels. 43 Furthermore, APE1/Ref-1 protein expression levels are elevated in renin-dependent, aortic coarctation hypertensive rat models. 50 An association between hypertension and APE1/Ref-1 gene polymorphism has been observed in a human study and hence, the alterations in the APE1/Ref-1 gene can be an important target for essential hypertension. 51 Current knowledge provides an insight into the mechanisms under- 
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